First Venture Technologies Corp.

First Venture Technologies Corp.

April 10, 2007 09:00 ET

First Venture Reports the Start of Product Trials in South America

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - April 10, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) reports that product trials of the Company's proprietary yeasts are now underway with numerous commercial wineries in South America for the spring 2007 wine making season. South America is a significant wine making area whose production represents almost 10% of the globe's production, and two of its countries are among the world's top 10 producers. The participants in these fermentation evaluations include leading wineries, varying in size from small boutique to larger global market wine producers. Of primary consideration for these trial clients has been the interest in minimizing ethyl carbamate contaminant levels in wine while maintaining high product quality. As such, the wineries are seeking to confirm that wines produced with First Venture's proprietary yeasts do not differ in terms of sensory attributes and fermentation kinetics from wines produced with comparative commercial yeast strains.

It is expected that these trials will provide, under a wide-range of commercial winemaking conditions, similar fermentation and wine product results as determined in lab trials conducted at the Wine Research Centre at The University of British Columbia, as well as commercial trials run this past crush in North America.

"We continue to be very pleased with the cooperation and commitment of the global wine industry as a whole, and now these South American wineries, who continue to show strong interest to the prospect of being able to minimize an ethyl carbamate contaminant exposure as evidenced by their willingness to trial our yeasts to further improve wine product quality," said Andy Starr, First Venture Yeast Products' Director of Marketing & Business Development. "Their interest in using our yeasts now is made even more pertinent by the recent news of the World Health Organization's International Agency for Research on Cancer's reclassification of ethyl carbamate from a Group 2B possible human carcinogen now to a Group 2A probable human carcinogen. This is the first of many of our yeast product introductions outside of the USA, as we continue to answer customer inquiries and work with the wine industry (and other food and beverage sectors at risk) to minimize the natural occurrence of ethyl carbamate in its products."


Howard Louie, President & CEO


First Venture is a biotechnology company that develops and commercializes advanced yeast products. The company is currently commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. The company has licensed the exclusive worldwide rights to the technology from The University of British Columbia (UBC), and is developing the technology in partnership with UBC's world-renowned Wine Research Centre.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information